Shaping  the  Future  of  Medicine…    from  be6er  drugs  to  8ssue  on-­‐demand  

Sharon  Presnell,  Ph.D.  Chief  Technology  Officer      

© Copyright 2013, Organovo Holdings, Inc. This report is solely for the use of intended audience. No part of it may be circulated, quoted, or reproduced for distribution outside the organization without prior written

approval from Organovo Holdings, Inc.

SAFE HARBOR STATEMENT

2  

NYSEMKT:  ONVO    

©Copyright  2013  Organovo,  Inc.  

Any   statements   contained   in   this   presentaAon   that   do   not   describe   historical   facts   may  consAtute   forward-­‐looking   statements   as   that   term   is   defined   in   the   Private   SecuriAes  LiAgaAon  Reform  Act  of  1995.  Any  forward-­‐looking  statements  contained  herein  are  based  on  current  expectaAons,  but  are  subject  to  a  number  of  risks  and  uncertainAes.  The  factors  that  could  cause  actual   future   results   to  differ  materially   from  current  expectaAons   include,  but  are  not  limited  to,  risks  and  uncertainAes  relaAng  to  the  Company's  ability  to  develop,  market  and   sell   products   based   on   its   technology;   the   expected   benefits   and   efficacy   of   the  Company’s  products  and  technology;  the  availability  of  substanAal  addiAonal  funding  for  the  Company   to   conAnue   its   operaAons   and   to   conduct   research   and   development,   clinical  studies   and   future   product   commercializaAon;   and,   the   Company's   business,   research,  product  development,   regulatory  approval,  markeAng  and  distribuAon  plans  and  strategies.  These  and  other  factors  are  idenAfied  and  described  in  more  detail  in  our  filings  with  the  SEC,  including  our  annual  report  for  the  period  ended  December  31,  2012    on  Form  10-­‐K  and  our  current   reports   filed   on   Form   8K.   We   do   not   undertake   to   update   these   forward-­‐looking  statements  made  by  us.    

3  

4  

KIDNEY  DONORS   Data  Sources:  •  USRDS  •  UNOS  

KIDNEY  TRANSPLANT  WAITLIST  

5  

KIDNEY  DONORS   Data  Sources:  •  USRDS  •  UNOS  

KIDNEY  TRANSPLANT  WAITLIST  

PEOPLE  WITH  END-­‐STAGE  RENAL  FAILURE  

PEOPLE  WITH  MID-­‐  TO  LATE-­‐STAGE  CKD  

Target  Discovery   Lead  ID   Lead  Op<miza<on   ADMET   Development   Registra<on  

and  approval  

6  

Living human cells are widely used in drug development and regenerative medicine

©Copyright  2013  Organovo,  Inc.  

CELL-­‐BASED  ASSAYS   CELLS  &  TISSUES  AS  THERAPEUTIC  AGENTS  

From  Zreiqat  et  al.,  Biomaterials  2010  31:3175    

7  

(NYSEMKT:  ONVO)  

•  Founded  in  2007,  based  on  proprietary  bio-­‐prinAng  technology  developed  at  the  University  of  Missouri  with  a  $5M  NaAonal  Science  FoundaAon  grant  

•  Based  in  San  Diego  in  a  15,000  sq  i  facility  with  dedicated  bioprinAng    /  Assue  culture  and  analyAcal  laboratories  

 •  A  leader  in  “3D  prinAng”  of  human  Assue  targeAng  in  

vitro  and  in  vivo  applicaAons  

2012

©Copyright  2013  Organovo,  Inc.  

8  

Peripheral  Nerve  

Lung  

Bone  

Blood  Vessel  

Skeletal  Muscle  

Liver  

Cardiac  

©Copyright  2013  Organovo,  Inc.  

Organovo’s 3D Human Liver Tissue Array

Standard  Corning  TranswellTM  Plates    

•  Automated,  reproducible  •  Represents  naAve  human  Assue  

10  ©Copyright  2013  Organovo,  Inc.  

NATIVE  LIVER  TISSUE   ONVO  3D  LIVER  TISSUE   LIVER  CELLS  ON  3D  SCAFFOLD  

From  Mat  Sci  Eng  2012  C32:310  

Organovo’s 3D Human Liver Tissue Array •  Automated,  reproducible  •  Represents  naAve  human  Assue  •  Exhibits  superior  funcAon  

11  ©Copyright  2013  Organovo,  Inc.  

   ONVO                Standard  3D                              2D          

LIVE

R-­‐SPEC

IFIC  PRO

TEIN  SEC

RETION  

(ng  Albu

min  /  mL  /  m

illion  cells)  

 *    p  <  0.001  

Enabling blood supply… A critical step in building implantable tissues

From  establishing  microvascular  networks…    …to  simple  blood  vessels    

…to  branched  vascular  trees    Vascular  Networks  (brown)  in  

bioprinted  human  Assue  

Bioprinted  Branched  Vessel  

13  ©Copyright  2013  Organovo,  Inc.  

Partner Companies & Institutions